VICE PRESIDENTPfizerCambridge, Massachusetts, United States
Disclosure information not submitted.
Transformational efficacy for type 2 cytokine-driven disease with multi-functional antibody therapeutics
Friday, April 17, 20269:45 AM - 11:15 AM US ET